Key Highlights
- ZARS Pharma specializes in developing topical anesthetics using proprietary drug delivery technologies, offering non-invasive pain management solutions.
- The company's flagship products, Synera and Pliaglis, are approved for use in various medical and cosmetic procedures, demonstrating their effectiveness and safety.
- ZARS Pharma's innovative technologies, CHADD and Peel, enable the delivery of local anesthetics through the skin, providing a unique approach to pain management.
- The company has a strong presence in both the U.S. and European markets, with Synera marketed in the U.S. and Europe under the name Rapydan, and Pliaglis marketed worldwide by Galderma.
- ZARS Pharma's commitment to innovation and patient care is evident in its ongoing development of new products, aiming to expand its portfolio of topical anesthetics.
About ZARS Pharma
ZARS Pharma is a specialty pharmaceutical company based in Salt Lake City, Utah, focused on developing and commercializing topically administered drugs using proprietary drug delivery technologies, primarily in pain management. The company has two approved products: Synera and Pliaglis. Synera, a topical patch, provides local dermal anesthesia for procedures like venous access and immunization injections, while Pliaglis, a cream, offers anesthesia for cosmetic procedures such as laser surgery and dermal filler injections. ZARS Pharma was founded in 1996 and employs 15 people.
ZARS Pharma's proprietary technologies, CHADD and Peel, enable the effective delivery of local anesthetics through the skin. Synera is marketed in the United States and Europe, with EuroCept handling European distribution under the name Rapydan. Pliaglis is marketed worldwide by Galderma, which holds the worldwide marketing rights. ZARS Pharma continues to innovate in the field of topical anesthetics, with several products in various stages of development.
The company's focus on pain management and its innovative drug delivery technologies make it a key player in the specialty pharmaceutical sector. ZARS Pharma's commitment to improving patient experiences during medical procedures positions it as a leader in the development of non-invasive anesthetic solutions.
Why Contact ZARS Pharma?
B2B professionals should contact ZARS Pharma for opportunities in the specialty pharmaceutical sector, particularly in pain management and topical anesthetics. The company's innovative technologies and approved products offer potential for partnerships and vendor opportunities.
Who Should Contact ZARS Pharma for Business?
Sales teams targeting the pharmaceutical and medical device sectors, recruiters seeking roles in drug development and delivery technologies, and partners interested in specialty pharmaceuticals should reach out to ZARS Pharma.
Categories
- topical anesthetics
- pain management
- drug delivery technologies
- specialty pharmaceuticals
- Synera
- Pliaglis
- CHADD technology
- Peel technology
- local dermal anesthesia
- cosmetic procedures
More Specialty Pharmaceuticals Companies
Frequently Asked Questions
- How many employees does ZARS Pharma have?
- ZARS Pharma has approximately 15 employees.
- Where is ZARS Pharma headquartered?
- Salt Lake City, Utah, United States of America
- What industry is ZARS Pharma in?
- ZARS Pharma operates in Specialty Pharmaceuticals, Pain Management, Topical Anesthetics.
- When was ZARS Pharma founded?
- ZARS Pharma was founded in 1996.
- What is the email format at ZARS Pharma?
- ZARS Pharma uses the email format flast@zars.com.
- Is ZARS Pharma still active?
- Yes, ZARS Pharma was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to ZARS Pharma?
- Research ZARS Pharma's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to ZARS Pharma?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with ZARS Pharma